Articles / Media Interviews

Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial

Carly Siu Yin Lam,¹ Wing Chun Tang,¹ Dennis Yan-yin Tse,¹ Roger Pak Kin Lee,¹ Rachel Ka Man Chun,¹ Keigo Hasegawa,² Hua Qi,² Takashi Hatanaka,² and Chi Ho To¹

Two-Year Clinical Trial of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: Phase 2 Report

Jason C. Yam, FCOphthHK, FRCS (Edin),^1,2,3 Fen Fen Li, MMed,¹ Xiujuan Zhang, PhD,¹ Shu Min Tang, PhD,^1,4 Benjamin H.K. Yip, PhD,⁵ Ka Wai Kam, FCOphthHK, FHKAM (Ophthalmology),^1,3 Simon T. Ko, FCOphthHK, FHKAM (Ophthalmology),⁶ Alvin L. Young, FRCSI,^1,3 Clement C. Tham, FCOphthHK, FRCOphth,^1,2,3Li Jia Chen, FCOphthHK, PhD,^1,3 Chi Pui Pang, Dphil¹

When To Start Myopia Management

Cassandra Haines

Overnight Orthokeratology for Myopia: What Does the Evidence Say?

Jennifer S. Harthan, OD, FAAO, FSLS

Dr. Thakrar’s recent CBC interview on children’s vision during the pandemic

Role of rigid gas-permeable scleral contact lenses in the management of advanced atopic keratoconjunctivitis

Keratoconus diagnosis with optical coherence tomography pachymetry mapping

EyePrintPRO therapeutic scleral contact lens: indications and outcomes

Endothelial dysfunction after scleral lens use in patients with herpetic eye disease

Management of patients with ocular neuropathic pain

Why I Switched to Daily Contact Lenses

INSIGHT WITH DR. VISHAKHA THAKRAR